Creating a DDAVP Releasable Pool of Factor VIII: Its Impact on the Gene Therapy of Hemophilia a † 786

Pediatric Research - United States
doi 10.1203/00006450-199804001-00807
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

244. Factor VIII Immunogenicity Is a Barrier to AAV Gene Therapy for Hemophilia A

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Lentivirus-Mediated Platelet Gene Therapy of Murine Hemophilia a With Pre-Existing Anti-Factor VIII Immunity

Journal of Thrombosis and Haemostasis
MedicineHematology
2012English

Generation of an Optimized Lentiviral Vector Encoding a High-Expression Factor VIII Transgene for Gene Therapy of Hemophilia A

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2012English

Improving the Performance of Factor VIII Inhibitor Tests in Hemophilia A

Thrombosis Research
Hematology
2015English

Postpartum Acquired Hemophilia Factor VIII �nhibitors and Response to Therapy

Turkish Journal of Haematology
Hematology
2012English

Effect of Route of Administration of Human Recombinant Factor VIII on Its Immunogenicity in Hemophilia a Mice

Journal of Pharmaceutical Sciences
Pharmaceutical Science
2009English

Immune Tolerance Induced by Platelet-Targeted Factor VIII Gene Therapy in Hemophilia a Mice Is CD4 T Cell-Mediated

Journal of Thrombosis and Haemostasis
MedicineHematology
2017English

Expression of Human Coagulation Factor VIII in Adipocytes Transduced With the Simian Immunodeficiency Virus agmTYO1-based Vector for Hemophilia a Gene Therapy

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2004English

The Impact of Factor VIII/von Willebrand Factor Products in Inhibitor Development and Management of Patients With Hemophilia a With Inhibitors

Oncology & Hematology Review (US)
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy